NeuroGenomeX, Inc.

Scientific Advisory Board

Dr. Sutula chairs the Scientific Advisory Board, which includes experts in neurobiology, molecular biology, neural plasticity, and diseases of the nervous system. The Board provides scientific advice and guidance to NGX management regarding opportunities and feasibility of potential new drug targets, and also provides guidance for development of infrastructure, new technical opportunities, and the setting of future research and development priorities.

Paolo Calabresi, MD

University of Rome, Italy
Basal ganglia, neurodegenerative disorders, antiepileptic and neuroprotective drugs

Orin Devinsky, MD

New York University Medical Center
Epilepsy diagnosis and treatment

Jacqueline French, MD

New York University Medical Center
Clinical trials of anticonvulsant drugs

John Freeman, MD

Johns Hopkins University
Ketogenic diet for epilepsy therapy

Asla Pitkanen, MD, PhD

A.I. Virtanen Institute, University of Kuopio, Finland
Central nervous system trauma and epilepsy